T1	Disease	69 97	EGFR -mutated NSCLC patients
T2	Gene_or_protein	118 127	EGFR -TKI
T3	Chemical	118 132	EGFR -TKI used
T4	Chemical	322 333	itinib rech
T5	Disease	350 372	mutated NSCLC patients
T6	Chemical	410 466	I followed by a subsequent line of treatment ( excluding
T7	Chemical	475 481	Is ) .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	treats	Arg1:T1	Arg2:T5
R4	isAssociatedWith	Arg1:T1	Arg2:T7
R5	treats	Arg1:T2	Arg2:T1
R6	influences	Arg1:T2	Arg2:T3
R7	influences	Arg1:T2	Arg2:T4
R8	treats	Arg1:T2	Arg2:T5
R9	treats	Arg1:T2	Arg2:T6
R10	treats	Arg1:T2	Arg2:T7
R11	treats	Arg1:T3	Arg2:T1
R12	influences	Arg1:T3	Arg2:T2
R13	influences	Arg1:T3	Arg2:T4
R14	treats	Arg1:T3	Arg2:T5
R15	treats	Arg1:T3	Arg2:T6
R16	treats	Arg1:T3	Arg2:T7
R17	treats	Arg1:T4	Arg2:T1
R18	influences	Arg1:T4	Arg2:T2
R19	influences	Arg1:T4	Arg2:T3
R20	treats	Arg1:T4	Arg2:T5
R21	influences	Arg1:T4	Arg2:T6
R22	treats	Arg1:T5	Arg2:T1
R23	isAssociatedWith	Arg1:T5	Arg2:T2
R24	isAssociatedWith	Arg1:T5	Arg2:T3
R25	isAssociatedWith	Arg1:T5	Arg2:T4
R26	isAssociatedWith	Arg1:T5	Arg2:T6
R27	isAssociatedWith	Arg1:T5	Arg2:T7
R28	treats	Arg1:T6	Arg2:T1
R29	influences	Arg1:T6	Arg2:T2
R30	influences	Arg1:T6	Arg2:T3
R31	influences	Arg1:T6	Arg2:T4
R32	treats	Arg1:T6	Arg2:T5
R33	treats	Arg1:T6	Arg2:T7
R34	treats	Arg1:T7	Arg2:T1
R35	influences	Arg1:T7	Arg2:T2
R36	influences	Arg1:T7	Arg2:T3
R37	influences	Arg1:T7	Arg2:T4
R38	treats	Arg1:T7	Arg2:T5
R39	influences	Arg1:T7	Arg2:T6
